Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies.
OBJECTIVE:The optimal sequencing of targeted therapies for metastatic renal cell carcinoma (mRCC) is unknown. Observational studies with a variety of designs have reported differing results. The objective of this study is to systematically summarize and interpret the published real-world evidence co...
Main Authors: | Daniel Y Heng, James Signorovitch, Elyse Swallow, Nanxin Li, Yichen Zhong, Paige Qin, Daisy Y Zhuo, Xufang Wang, Jinhee Park, Sotirios Stergiopoulos, Christian Kollmannsberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4262396?pdf=render |
Similar Items
-
Review: Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions
by: Daniel Y.C. Heng, et al.
Published: (2010-01-01) -
Real-world data of second-line immunotherapy in metastatic clear cell renal cell carcinoma: A retrospective study
by: Waseem Abbas, et al.
Published: (2021-01-01) -
Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers
by: Andreea Ioana Parosanu, et al.
Published: (2023-07-01) -
Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma
by: Iraklis C. Mitsogiannis, et al.
Published: (2022-09-01) -
Real-life data of Nivolumab in second-line metastatic renal cell cancer
by: L.F. Sánchez-Cousido, et al.
Published: (2020-11-01)